Navigation Links
New research program BioInterfaces launched
Date:6/8/2009

This will lead, for example, to new ways of growing stem cells, or manipulating cells in the organism and in bioreactor systems. These key technologies will ultimately contribute to the development of new therapies for many degenerative diseases that affect muscle, the retina or the central nervous system. In addition, BioInterfaces aims to control or inhibit bacterial cells that form biofilms on man-made surfaces, another area of immense technical relevance.

"The basic philosophy of the BioInterfaces programme is to learn from nature and then copy it. So, the first stage of our strategy involves a focused, innovative, large-scale analysis to learn more about the natural control mechanisms of cells and how optimally to manipulate them", says Professor Uwe Strhle, speaker of the program and head of the Institute of Toxicology and Genetics. "This will be achieved by a close partnership between biologists and technology developers. In the subsequent stages, multifunctional molecular devices or advanced surface modifications will be designed and built in order to target and interact with the key molecular control points and thereby to control cell behaviour."

The interdisciplinary nature of the BioInterfaces programme demands a new generation of scientists. The programme has therefore just launched the BioInterfaces Postgraduate School that will provide interdisciplinary training for approximately 90 PhD students. Students will be offered introductory courses covering all the participating disciplines. This school will foster cross-talk between the BioInterfaces research fields through the funding of interdisciplinary and "twinning" student projects.

Reflecting the Helmholtz research philosophy, the BioInterfaces researchers have access to or operate large scale infrastructures such as the largest fish facility in Europe, the ANKA synchrotron radiation source, a large computing and data storage facility, microand nano-fabrication facilities, and advanced surface analysis technology. The programme is based at the campus north of KIT, the Forschungszentrum Karlsruhe. This large Helmholtz research center encompasses a research expertise in micro- and nanotechnology but is also the home for basic biology research. Importantly, BioInterfaces establishes a regional focus since it involves a strong partnership with the University of Heidelberg, recently promoted to the "elite class" of German universities. Strategically, BioInterfaces represents a key programme that demonstrates the great potential offered by KIT.


'/>"/>

Contact: Dr. Elisabeth Zuber-Knost
pressestelle@kit.edu
49-072-160-87414
Helmholtz Association of German Research Centres
Source:Eurekalert  

Related biology news :

1. University of Saskatchewan and Canadian Synchrotron researchers shed light on esophageal disease
2. Government of Canada announces funding for research on the H1N1 flu virus
3. Faculty of Translational Medicine boosts support for biomedical researchers
4. USC researchers present diabetes findings at American Diabetes Association Scientific Sessions
5. MSU researchers receive $400,000 in first wave of stimulus funding
6. Shock and kill research gives new hope for HIV-1 eradication
7. Researchers engineer metabolic pathway in mice to prevent diet-induced obesity
8. Women faring well in hiring process for science faculty jobs at research universities
9. SRI International announces findings from new upper atmospheric radar system for scientific research
10. Elevated water temperature and acidity boost growth of key sea star species: UBC researchers
11. Penn researchers discover genetic risk factor for testicular cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New research program BioInterfaces launched
(Date:2/3/2017)... A new independent identity strategy consultancy firm ... . Designed to fill a critical niche in technical ... partners Mark Crego and Janice Kephart ... identity expertise that span federal governments, the 9/11 Commission, ... combined expertise has a common theme born from a ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... ... ... ACEA Biosciences, a pioneer in cell analysis instrumentation and the development of ... as the new Vice President of Global Clinical Development. With more than 15 ... will now team with Dr. Li Xu, Chief Medical Officer, and Dr. Xiao Xu, ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... science and biotechnology companies today announced it named Joan Siefert Rose as ... out of Durham, NC and will begin work immediately. , Rose most recently ...
(Date:2/28/2017)... , Feb. 28, 2017 Sangamo ... genome editing, today reported its fourth quarter and ... "Early this year we rebranded our ... clinical development of genomic therapies using our industry ... gene regulation and cell therapy," said Sandy ...
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
Breaking Biology Technology: